Bactiguard has been informed that the European Patent Office (EPO) intends to grant a European patent for Bactiguard's infection prevention technology. The new patent, which is the third generation, will provide extensive worldwide protection for the Bactiguard technology until 2039.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
70 SEK | -3.85% | +0.29% | +13.27% |
14/05 | Bactiguard Holding Ab Appoints Thomas Von Koch as the Chairman of the Board of Directors | CI |
25/04 | Transcript : Bactiguard Holding AB, Q1 2024 Earnings Call, Apr 25, 2024 |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+13.27% | 24Cr | |
+5.98% | 2.65TCr | |
-39.95% | 266.53Cr | |
-21.34% | 237.06Cr | |
+17.78% | 227.65Cr | |
+9.63% | 226.97Cr | |
-13.64% | 182.86Cr | |
+15.56% | 178.63Cr | |
+21.61% | 132.03Cr | |
-3.29% | 126.86Cr |
- Stock Market
- Equities
- BACTI B Stock
- News Bactiguard Holding AB
- Bactiguard Announces European Patent Office Intends to Grant A European Patent for Bactiguard's Infection Prevention Technology